how much weight can you lose with retatrutide Is Loss the Future of Peptide Weight Loss Therapy? Retatrutide – The New Weight

Other research highlights: 30% of GLP-1 users tested positive for SIBO or IMO even after accounting for diabetes (5) GLP-1 medicines caused microbiome changes and altered metabolism in mice (6) GLP-1 medicines tested in humans only had noticeable microbiome changes by 48 weeks (7) Despite not necessarily having slower gut motility, one study found that 88.9% of obese patients had SIBO (8) A meta analysis of people with IBS symptoms, found that up to 78% of people had SIBO, many of whom were undiagnosed (9) Overall, Sun and colleagues (1) could not prove a mechanistic link between GLP-1 medications and SIBO, however they did find that SIBO was twice as likely in GLP-1 users

Over time, this leads to consistent weight loss

Both drugs are approved for patients with Type 2 diabetes and heart disease

To learn more, read How To Use Your Incentive Spirometer

Compounded semaglutide and tirzepatide are prepared by licensed 503A or 503B compounding pharmacies in the U.S